A huge quarter for Ozempic and Wegovy maker Novo Nordisk is masking a longer-term challenge ...Middle East

Soaring demand for weight loss injectables boosted Danish drugmaker Novo Nordisk’s sales 29% year-over-year in the third quarter, with revenues of $8.58 billion (58.73 billion Danish krone). Its earnings of 73 cents a share beat Zacks Investment Research analyst estimates of 69 cents.Read more...

Hence then, the article about a huge quarter for ozempic and wegovy maker novo nordisk is masking a longer term challenge was published today ( Thursday 02/11/2023 - 09:12 PM ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( A huge quarter for Ozempic and Wegovy maker Novo Nordisk is masking a longer-term challenge )

Also on site :

• Apple Blocks US Users From Downloading ByteDance’s Chinese Apps
• Drone Strike Hits Bahrain Refinery as Crack Spreads Surge
• Oil Tanker Hit By Blast Near Kuwait, Major Leak Reported